PhRMA gets defensive on eve of new “Dollars for Docs” report

A new edition of the ProPublica “Dollars for Docs” project she wrote:

“…biopharmaceutical companies are not just gatherers of clinical data, they are disseminators of that data, as well. After all, that information can’t help one patient if it doesn’t get to the physician first.”

Oh, this is going to be a fun exchange to follow.

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Dr Joe

September 12, 2011 at 9:43 pm

Funny how the information does not need to get to physicians when the finding is negative about drugs.